Gavin A. Cloherty, Ph.D., is head of Infectious Disease Research for Abbott's diagnostics business. He provides scientific leadership in the area of infectious disease diagnostics by conducting groundbreaking clinical studies on hepatitis and HIV and developing new tests. As one of the top experts in the field, his innovative research is changing the way infectious diseases are being diagnosed to help improve patient outcomes. Gavin has more than 20 years of experience with Abbott and leads a team of scientists in the study of the viral diversity of HIV and hepatitis. His expertise is sought after globally through his established partnerships with commercial organizations, ministries of health, government agencies and academic institutions, such as the Centers for Disease Control and Prevention (CDC) and National Institutes of Health's AIDS Clinical Trial Group (ACTG) and Hepatitis B Research Network (HBRN). He has worked with the Republic of Georgia to help eradicate hepatitis C in the country, and is looking to expand these efforts to other regions of the world severely impacted by this disease. As a senior research scientist, Gavin assisted in the development and design of the Abbott Molecular RealTime tests and m2000 system. Throughout his career Gavin has published numerous studies, abstracts and posters. In addition to his impressive list of publications he also has been invited to speak at conferences around the world. Gavin graduated from the National University of Ireland, Galway, where he received his Ph.D. in molecular biology and a Bachelor of Science in microbiology and zoology. Gavin is a member of numerous professional and scientific societies, including the International AIDS Society and the American Association for the Study of Liver Disease. He also is a contributor to multiple editorial boards, including the Journal of Clinical Microbiology and Journal of Clinical Virology.